Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
7.72
-0.31 (-3.92%)
At close: Aug 1, 2025, 4:00 PM
7.40
-0.31 (-4.08%)
After-hours: Aug 1, 2025, 6:49 PM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $687.72 million as of August 1, 2025. Its market cap has increased by 377.02% in one year.
Market Cap
687.72M
Enterprise Value
485.04M
1-Year Change
377.02%
Ranking
Category
Stock Price
$7.72
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has decreased from $1.07B to $687.72M, a decrease of -35.68%. That is a compound annual growth rate of -11.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 687.72M | 167.23% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.55B |
| Novo Nordisk | 213.92B |